In a 36-year-old woman with a prior abnormal Pap test two years ago that led to a cervical biopsy (biopsy results unavailable) and a current Pap test showing negative cytology but positive high-risk HPV of unknown genotype, what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management Recommendation

This patient requires colposcopy now, not repeat testing in 1 year. The combination of a prior abnormal Pap with biopsy (suggesting previous high-risk findings) and current HPV-positive/cytology-negative result places her at elevated risk that warrants immediate colposcopic evaluation.

Clinical Reasoning

Why Immediate Colposcopy is Indicated

The 2019 ASCCP Risk-Based Management Guidelines 1 use a risk-stratification framework based on CIN3+ risk rather than isolated test results. The critical determining factor here is the patient's prior screening history.

According to the 2021 CDC/ASCCP guidelines 1:

  • If a patient has HPV-positive/cytology-negative results AND was preceded by a negative screening HPV test or cotest within the past 5 years, then repeat testing in 1 year is appropriate
  • However, if the previous screening was NOT negative (or is unknown), colposcopy is recommended 1

Application to This Case

Your patient had:

  • An abnormal Pap 2 years ago that led to biopsy (results unknown)
  • Current HPV-positive/NILM result

This does NOT meet criteria for the low-risk pathway because:

  1. The prior test 2 years ago was abnormal (not negative)
  2. The biopsy results are unavailable, meaning you cannot confirm she had low-grade disease that was adequately treated or regressed
  3. Per the guidelines 1, two consecutive HPV-positive tests always warrant colposcopy, regardless of cytology results

The guideline table explicitly states: "Previous Pap test results do not modify the recommendation; colposcopy is always recommended for two consecutive HPV-positive tests" 1.

Risk Assessment

The absolute risk data supports this approach:

  • Women with HPV-positive/cytology-negative results have a 3-year cumulative CIN3+ risk of approximately 4.6% 2
  • When there is a history of prior abnormality, this risk increases substantially 1
  • Research shows that 6.4% of HPV-positive/cytology-negative women develop LSIL or worse, and 2.2% develop HSIL or worse within 5 years 3
  • All cases of HSIL in one study were diagnosed after the second positive HPV test 4

Critical Pitfall to Avoid

Do not defer to 1-year follow-up simply because current cytology is negative. The guidelines specifically note that "negative HPV test or cotest results only reduce risk sufficiently to defer colposcopy if performed for screening purposes within the last 5 years. Colposcopy is still warranted if negative HPV test or cotest results occurred in the context of surveillance for a previous abnormal result" 1.

Management Algorithm

Immediate Actions:

  1. Refer to colposcopy with biopsy of any visible lesions
  2. Consider HPV genotyping if not already done (particularly for HPV 16/18) 1, 2
  3. Perform endocervical curettage if colposcopy is unsatisfactory or if glandular abnormality is suspected

At Colposcopy:

  • If CIN2+ is found: treat per standard protocols
  • If CIN1 or less: repeat HPV testing with or without cytology in 1 year 1
  • If no lesion identified: still repeat testing in 1 year given persistent HPV positivity

Follow-up Strategy:

After colposcopy and any indicated treatment, surveillance should include co-testing (HPV + cytology) rather than cytology alone, as HPV testing has higher negative predictive value 1.

Additional Considerations

Attempt to Obtain Prior Biopsy Results

While management should proceed to colposcopy regardless, obtaining the 2-year-old biopsy results would be valuable for:

  • Risk stratification
  • Determining if this represents persistent disease
  • Guiding intensity of surveillance after current evaluation

Patient Counseling Points

  • Emphasize the importance of attending colposcopy appointment
  • Explain that HPV persistence (not just presence) increases cancer risk
  • Discuss that most HPV infections clear, but persistent infections require monitoring
  • Address that colposcopy is diagnostic, not necessarily treatment

The evidence strongly supports immediate colposcopy rather than observation in this clinical scenario 1, 4.

References

1
Guideline

sexually transmitted infections treatment guidelines, 2021.

MMWR Recommendations and Reports, 2021

Related Questions

What is the recommended next step for a patient with a normal Pap smear but high‑risk HPV type 16 positive?
For a 25-year-old woman with ASC-US (atypical squamous cells of undetermined significance) and a positive high-risk HPV test that is not genotype 16 or 18, should I repeat the Pap smear in one year or wait until the postpartum period?
What is the recommended cervical cancer screening follow‑up for a 33‑year‑old woman whose most recent Pap test is negative for intraepithelial lesion or malignancy and HPV test is negative, after prior Pap tests showing NILM with positive high‑risk HPV (negative for types 16, 18, and 45) and a benign colposcopy with no transformation zone visualized?
In a 34-year-old healthy woman with no prior cervical dysplasia and a normal Pap smear but a positive high-risk HPV test, what is the appropriate next step in management?
What is the appropriate next step in management for a 34‑year‑old woman with persistent low‑grade squamous intraepithelial lesion (LSIL) and high‑risk HPV‑positive Pap smear after a prior benign colposcopy?
How can I obtain a prescription for azithromycin (Z‑Pack)?
What anti‑nausea medication is safe to use in a patient taking amiodarone?
What are the indications, dosing regimen, contraindications, and monitoring recommendations for Jornay PM (mixed‑amphetamine) when used to treat ADHD?
How can tranexamic acid (TXA) be used topically to control bleeding from a fingertip avulsion laceration when Surgicel fails, and what contraindications must be considered?
What does bronchial wall thickening on chest imaging signify?
What oral dose of sildenafil is equivalent to 20 mg of tadalafil for an adult male with erectile dysfunction and no contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.